NKTR ▼ -0.1% - Nektar Therapeutics
$NKTR NKTR - Nektar Announces Three Oral Presentations for Rezpegaldesleukin at the European Academy of Dermatology & Venereology (EADV) Congress 2026
28-SEP-2026 08:02 AM ET
Share this post
More filings for $NKTR
NKTR - Nektar Therapeutics - SEC Filing Update (28-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 28, 2026NKTR ▼ -4.0% - Nektar TherapeuticsSep 25, 2026NKTR ▼ -2.3% - Nektar TherapeuticsAug 28, 2026NKTR - Nektar Therapeutics - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$NKTR SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026$NKTR SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026
View full $NKTR filing history →💬 Comments
Loading comments…
Leave a comment